Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| intestine | 8 studies | 27% ± 12% | |
| kidney | 7 studies | 42% ± 10% | |
| lung | 5 studies | 52% ± 20% | |
| breast | 4 studies | 35% ± 13% | |
| uterus | 3 studies | 44% ± 26% | |
| bone marrow | 3 studies | 32% ± 9% | |
| pancreas | 3 studies | 39% ± 11% | |
| prostate | 3 studies | 26% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 43627.36 | 89 / 89 | 97% | 1764.59 | 878 / 901 |
| pancreas | 100% | 52577.91 | 328 / 328 | 88% | 689.22 | 157 / 178 |
| thymus | 100% | 63226.73 | 652 / 653 | 85% | 1249.06 | 517 / 605 |
| stomach | 75% | 23325.06 | 269 / 359 | 92% | 1087.56 | 263 / 286 |
| breast | 55% | 9354.87 | 254 / 459 | 89% | 1325.46 | 990 / 1118 |
| intestine | 45% | 19042.76 | 430 / 966 | 93% | 1007.12 | 492 / 527 |
| prostate | 64% | 5287.60 | 157 / 245 | 70% | 301.88 | 351 / 502 |
| esophagus | 39% | 32812.43 | 567 / 1445 | 85% | 873.61 | 156 / 183 |
| bladder | 29% | 2222.43 | 6 / 21 | 77% | 693.79 | 389 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 239.34 | 1 / 1 |
| ovary | 0% | 0 | 0 / 180 | 95% | 1147.75 | 407 / 430 |
| uterus | 16% | 1980.91 | 27 / 170 | 78% | 791.32 | 357 / 459 |
| lung | 15% | 1072.71 | 85 / 578 | 65% | 493.86 | 755 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 375.93 | 31 / 45 |
| adrenal gland | 5% | 333.02 | 13 / 258 | 51% | 348.78 | 117 / 230 |
| skin | 51% | 3559.69 | 926 / 1809 | 2% | 5.39 | 9 / 472 |
| liver | 6% | 486.10 | 14 / 226 | 29% | 132.70 | 119 / 406 |
| peripheral blood | 23% | 2279.53 | 216 / 929 | 0% | 0 | 0 / 0 |
| brain | 6% | 440.21 | 148 / 2642 | 13% | 64.19 | 93 / 705 |
| spleen | 10% | 637.49 | 25 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 32.11 | 3 / 29 |
| adipose | 0% | 45.39 | 6 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 16.19 | 3 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 12.91 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072139 | Biological process | glomerular parietal epithelial cell differentiation |
| GO_0002768 | Biological process | immune response-regulating cell surface receptor signaling pathway |
| GO_2000768 | Biological process | positive regulation of nephron tubule epithelial cell differentiation |
| GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
| GO_0045730 | Biological process | respiratory burst |
| GO_0072112 | Biological process | podocyte differentiation |
| GO_0043627 | Biological process | response to estrogen |
| GO_0032600 | Biological process | chemokine receptor transport out of membrane raft |
| GO_0022407 | Biological process | regulation of cell-cell adhesion |
| GO_0032597 | Biological process | B cell receptor transport into membrane raft |
| GO_0002237 | Biological process | response to molecule of bacterial origin |
| GO_0031295 | Biological process | T cell costimulation |
| GO_0001959 | Biological process | regulation of cytokine-mediated signaling pathway |
| GO_0042325 | Biological process | regulation of phosphorylation |
| GO_0043406 | Biological process | positive regulation of MAP kinase activity |
| GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
| GO_0001775 | Biological process | cell activation |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0001666 | Biological process | response to hypoxia |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0043408 | Biological process | regulation of MAPK cascade |
| GO_0032913 | Biological process | negative regulation of transforming growth factor beta3 production |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0016477 | Biological process | cell migration |
| GO_0030856 | Biological process | regulation of epithelial cell differentiation |
| GO_0042632 | Biological process | cholesterol homeostasis |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0045121 | Cellular component | membrane raft |
| GO_0016020 | Cellular component | membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0030296 | Molecular function | protein tyrosine kinase activator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CD24 |
| Protein name | Signal transducer CD24 (Small cell lung carcinoma cluster 4 antigen) (CD antigen CD24) CD24 molecule |
| Synonyms | CD24A |
| Description | FUNCTION: May have a pivotal role in cell differentiation of different cell types. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Modulates B-cell activation responses. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells . In association with SIGLEC10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90. Plays a role in the control of autoimmunity (By similarity). . |
| Accessions | ENST00000606017.2 [P25063-1] ENST00000610952.1 [P25063-1] A0A087WU21 P25063 A0A087WW33 ENST00000620405.1 ENST00000622315.1 [P25063-2] ENST00000615659.1 ENST00000619869.1 ENST00000619133.4 [P25063-1] A0A087WU87 |
